日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficient mRNA delivery to resting T cells to reverse HIV latency.

将mRNA高效递送至静息T细胞以逆转HIV潜伏期

Cevaal Paula M, Kan Stanislav, Fisher Bridget M, Moso Michael A, Tan Abigail, Liu Haiyin, Ali Abdalla, Tanaka Kiho, Shepherd Rory A, Kim Youry, Ong Jesslyn, Furtado Denzil L, Holz Marvin, Purcell Damian F J, Casan Joshua M L, Payne Thomas, Zhao Wei, Fareh Mohamed, McMahon James H, Deeks Steven G, Hoh Rebecca, Telwatte Sushama, Pouton Colin W, Johnston Angus P R, Caruso Frank, Symons Jori, Lewin Sharon R, Roche Michael

Hepatitis B surface antigen is upregulated by HIV Tat in an HIV-hepatitis B virus co-infection model system.

在 HIV-乙型肝炎病毒共感染模型系统中,乙型肝炎表面抗原受 HIV Tat 上调

Zhao Wei, Singh Kasha, Sozzi Vitini, Cevaal Paula, Rossello Fernando J, Martelotto Luciano, Zerbato Jennifer M, Rhodes Ajantha, Powell David R, Schröder Jan, Anderson Jenny, Tumpach Carolin, Fong Danielle, Revill Peter, Crane Megan, Grimmond Sean, Roche Michael, Audsley Jennifer, Lewin Sharon R

HIV Tat as a latency reversing agent: turning the tables on viral persistence

HIV Tat 作为潜伏期逆转剂:扭转病毒持续感染的局面

Fisher, Bridget M; Cevaal, Paula M; Roche, Michael; Lewin, Sharon R

CRISPR/Cas9 for achieving postintervention HIV control

利用 CRISPR/Cas9 技术实现干预后 HIV 控制

Moso, Michael A; Roche, Michael; Cevaal, Paula M; Lewin, Sharon R